Ghassan Jazayrly | Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy

University of Aleppo Faculty of Medicine

Medical School

UCSF - Fresno

Internship

University of Southern California - LAC+USC Medical Center

Residency

University of California Davis

Fellowship

American Board of Internal Medicine - Oncology

Glendale Adventist Medical Center

Languages: English/Spanish

(818) 409-8000

1509 Wilson Terrace

Glendale, California 91206

The price of remission.

Al-Jazayrly, G., Lau, D. H.; West J Med. 1997 Mar.

Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.

Lim, N., Lara, P. N., Lau, D. H., Edelman, M. J., Tanaka, M., al-Jazayrly, G., Houston, J., Lauder, I., Gandara, D. R.; Cancer Invest. 2003.

Bio & Insurance Information

Insurance Accepted

Aetna Cigna Health Net Humana MultiPlan United Healthcare
Education & Training

University of Aleppo Faculty of Medicine
Medical School
UCSF - Fresno
Internship
University of Southern California - LAC+USC Medical Center
Residency
University of California Davis
Fellowship
Board Certifications

American Board of Internal Medicine - Oncology
Hospital & Practice

Glendale Adventist Medical Center

Languages: English/Spanish

(818) 409-8000

1509 Wilson Terrace

Glendale, California 91206
Read More
Publications & Memberships

Dr. Ghassan Jazayrly has contributed to 2 publications.

The price of remission.

Al-Jazayrly, G., Lau, D. H.; West J Med. 1997 Mar.
See more >>

Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.

Lim, N., Lara, P. N., Lau, D. H., Edelman, M. J., Tanaka, M., al-Jazayrly, G., Houston, J., Lauder, I., Gandara, D. R.; Cancer Invest. 2003.
See more >>